{
    "nctId": "NCT03731845",
    "briefTitle": "Evaluation of Individual Sensitivity to the Gonadotoxicity of Chemotherapy in Young Patients With Breast Cancer",
    "officialTitle": "Evaluation of Individual Sensitivity to the Gonadotoxicity of Chemotherapy in Young Patients With Breast Cancer",
    "overallStatus": "ACTIVE_NOT_RECRUITING",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "SCREENING",
    "enrollmentCount": 73,
    "primaryOutcomeMeasure": "Assessment of ovarian reserve",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age: 18 - 36 years\n* Diagnosis of breast cancer\n* BMI\u226430 Kg/m2\n* Baseline antral Follicular count (before initiation of chemotherapy): 10-40 follicles measuring 2 - 9 mm in diameter\n* Regular and ovulatory menstrual cycles\n* Indication of neoadjuvant (4 FEC and 4 docetaxel) or adjuvant (3 FEC and 3 docetaxel) chemotherapy\n* Free informed and written consent, dated and signed by the patient and the investigator\n* Patient affiliated to the French National Social Security System\n\nNon inclusion criteria\n\n* Previous history of chemotherapy\n* History of ovarian surgery or endometrioma\n* Ovarian Polycystic Syndrome\n* DOR or POI before chemotherapy\n* Virgin patients\n\nExclusion Criteria:\n\n- Intensification of chemotherapy",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}